Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege

Breast cancers have been shown to elicit tumor-specific immune responses. As in other types of cancer, the antitumor immune response fails to contain breast tumor growth, and a reduction in both the quantity and cytotoxic effectiveness of tumor-infiltrating lymphocytes (TILs) is associated with a po...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: O’Connell, Joe, Bennett, Michael W., O’Sullivan, Gerald C., O’Callaghan, Jim, Collins, J. Kevin, Shanahan, Fergus
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 1999
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC95708/
https://ncbi.nlm.nih.gov/pubmed/10391843
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi